SDGC_STRSQ
ID SDGC_STRSQ Reviewed; 517 AA.
AC Q7X281;
DT 16-MAR-2016, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2003, sequence version 1.
DT 03-AUG-2022, entry version 68.
DE RecName: Full=Salicyloyl-CoA 5-hydroxylase {ECO:0000303|PubMed:15006746};
DE EC=1.14.13.209 {ECO:0000269|PubMed:15006746};
GN Name=sdgC {ECO:0000303|PubMed:15006746};
OS Streptomyces sp.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=1931;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, DISRUPTION
RP PHENOTYPE, AND INDUCTION.
RC STRAIN=WA46;
RX PubMed=15006746; DOI=10.1128/aem.70.3.1297-1306.2004;
RA Ishiyama D., Vujaklija D., Davies J.;
RT "Novel pathway of salicylate degradation by Streptomyces sp. strain WA46.";
RL Appl. Environ. Microbiol. 70:1297-1306(2004).
CC -!- FUNCTION: Involved in the degradation of salicylate via a pathway
CC involving coenzyme A derivative. Catalyzes the aromatic hydroxylation
CC of salicylyl-CoA to yield gentisyl-CoA. {ECO:0000269|PubMed:15006746}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2-hydroxybenzoyl-CoA + H(+) + NADH + O2 = 2,5-
CC dihydroxybenzoyl-CoA + H2O + NAD(+); Xref=Rhea:RHEA:48008,
CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:67148,
CC ChEBI:CHEBI:88147; EC=1.14.13.209;
CC Evidence={ECO:0000269|PubMed:15006746};
CC -!- INDUCTION: By salicylate. {ECO:0000269|PubMed:15006746}.
CC -!- DISRUPTION PHENOTYPE: Cells lacking this gene are unable to degrade
CC salicylate. {ECO:0000269|PubMed:15006746}.
CC -!- SIMILARITY: Belongs to the aromatic-ring hydroxylase family. KMO
CC subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB112586; BAC78378.1; -; Genomic_DNA.
DR AlphaFoldDB; Q7X281; -.
DR SMR; Q7X281; -.
DR KEGG; ag:BAC78378; -.
DR BioCyc; MetaCyc:MON-15920; -.
DR BRENDA; 1.14.13.209; 1284.
DR GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IMP:UniProtKB.
DR GO; GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW.
DR Gene3D; 3.50.50.60; -; 1.
DR InterPro; IPR002938; FAD-bd.
DR InterPro; IPR036188; FAD/NAD-bd_sf.
DR Pfam; PF01494; FAD_binding_3; 1.
DR SUPFAM; SSF51905; SSF51905; 1.
PE 1: Evidence at protein level;
KW Aromatic hydrocarbons catabolism; NAD; Oxidoreductase.
FT CHAIN 1..517
FT /note="Salicyloyl-CoA 5-hydroxylase"
FT /id="PRO_0000435737"
SQ SEQUENCE 517 AA; 56572 MW; E74499C0DCCD4CD5 CRC64;
MKVACIGAGP GGLFFATLLK RSRPDAEVVV FERNRPDDTF GFGVVFSDAT LDAIDAADPV
LSEALEKHGR HWDDIEVRVH GERERVGGMG MAAVVRKTLL SLLQERARAE GVQMRFQDEV
RDPAELDDFD LVVVCDGANS RFRTLFADDF GPTAEVASAK FIWFGTTYMF DGLTFVHQDG
PHGVFAAHAY PISDSLSTFI VETDADSWAR AGLDAFDPAT PLGMSDEKTK SYLEDLFRAQ
IDGHPLVGNN SRWANFATRR ARSWRSGKWV LLGDAAHTAH FSVGSGTKMA MEDAVALAET
LGEASRSVPE ALDLYEERRR PKVERIQNSA RPSLSWWEHF GRYVRSFDAP TQFAFHFLTR
SIPRGKLAVR DAAYVDRVDG WWLRHHEAGP LKTPFRVGPY RLPTRRVTVG DDLLTGTDGT
GIPMVPFSGQ PFGAGVWIDA PDTEEGLPLA LDQVRETAEA GVLLVGVRGG TALTRVLVAE
EARLAHSLPA AIVGAYDDDT ATTLVLSGRA DLVGGTK